Application of Emerging Technologies for Cancer Research (R21/R33)
The summary for the Application of Emerging Technologies for Cancer Research (R21/R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Application of Emerging Technologies for Cancer Research (R21/R33): This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits exploratory grant applications for research projects proposing the development of highly innovative cancer-relevant molecular biology technologies. Technology encompasses methods and tools that enable research, including but not limited to, instrumentation, techniques, and devices. -This FOA will utilize the NIH Phased Innovation Award (R21/R33) grant mechanisms and runs in parallel with two other FOAs of identical scientific scope, RFA-CA-07-017 and RFA-CA-07-018, that invite applications under the Exploratory/Developmental Grant (R21) award mechanism and the Exploratory/Developmental Phase II Grant (R33) award mechanism, respectively. -This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs. See NOT-CA-06-025. -Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. -The NCI intends to commit a total of up to $500,000 to this FOA in fiscal year 2007 to fund up to 4 grants. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -Budget and Project Period. An applicant for an R21/R33 grant may request a project period of up to 2 years and a budget for total direct costs of up to $275,000 for the R21 phase of the award, in keeping with standard R21 mechanism guidelines. In the R33 phase, an applicant may request a project period of up to 3 years and a budget appropriate for the science proposed. -Eligible Organizations: For profit organizations; non-profit organizations; public or private institutions, such as universities, colleges, hospitals and laboratories; units of State and local governments; eligible agencies of the Federal government; domestic or foreign institutions/organizations; faith-based or community-based organizations; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); and Indian/Native American Tribally Designated Organization -Eligible Project Directors/Principal Investigators (PDs/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Applicants may submit more than one application, provided each application is scientifically distinct.
|Federal Grant Title:||Application of Emerging Technologies for Cancer Research (R21/R33)|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Education Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-CA-07-019|
|Type of Funding:||Grant|
|CFDA Descriptions:||Cancer Construction 93.393 Cancer Cause and Prevention Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Sep 22, 2006|
|Posted Date:||May 02, 2006|
|Creation Date:||May 03, 2006|
|Archive Date:||Oct 22, 2006|
|Total Program Funding:||$500,000|
|Maximum Federal Grant Award:||$275,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||93.394 -- Cancer Detection and Diagnosis Research|
- Applicants Eligible for this Grant
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) City or township governments For profit organizations other than small businesses Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Special district governments Private institutions of higher education Independent school districts County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...